CSIMarket Company Name, Ticker, Competitors, else..
 

Caribou Biosciences Inc   (NASDAQ: CRBU)

Caribou Biosciences Inc 's

Competitiveness



Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

 

CRBU Sales vs. its Competitors Q1 2026


Comparing the current results to its competitors, Caribou Biosciences Inc reported Revenue increase in the 1 quarter 2026 by 1.87 % year on year, while most of its competitors have experienced contraction in revenues by -32.89 %, achieved in the same quarter.

• List of CRBU Competitors





Revenue Growth Comparisons




Net Income Comparison

Caribou Biosciences Inc , faster than the decline experienced by the competitors recorded a net loss, as well as most of its competitors.

<<  CRBU Stock Performance Comparisons





  

Overall company Market Share Q1 2026
With modest revenue growth of 1.87 % within Overall company, Caribou Biosciences Inc managed to improve its market share within this segment to approximately 0.62 %.
<<  More on CRBU Market Share.
 
*Market share is calculated based on total revenue.

  News about Caribou Biosciences Inc Contracts

Legal and Financial Crossroads Caribou Biosciences Strategic Dilemmas in a Competitive Landscape,

December 27, 2024
 Navigating Tumultuous Waters: Caribou Biosciences Faces Legal and Financial ChallengesIn an unfolding saga that blends legal complexity with financial turbulence, Caribou Biosciences, Inc. (NASDAQ: CRBU) finds itself at a pivotal juncture. Known for its pioneering work in genome editing, the company is grappling with a dual-front battle: a significant class action lawsuit and a sharp decline in revenue as compared to its competitors. This article delves into the intricacies of these challenges and their implications for the company’s future. Legal Repercussions: The Class Action LawsuitOn December 27, 2024, Bronstein, Gewirtz and Grossman, LLC, a prominent law firm with expertise in investor rights, issue...





Publicly Traded Peers of Caribou Biosciences Inc




Vor Biopharma Inc
Share Performance



-44.90%
One Year
Vor Biopharma Inc
Profile

Vor Biopharma Inc's business model focuses on developing novel cell therapies for the treatment of cancer.

More about Vor Biopharma Inc 's Market Share

Market Cap. Revenues TTM Net Income TTM
$ 966.900 mill. $ - mill. $ -883.080 mill.


Phoenix Biotech Acquisition Corp
Share Performance



0.00%
30 Days
Phoenix Biotech Acquisition Corp
Profile

Phoenix Biotech Acquisition Corp is a company that focuses on acquiring and investing in biotech businesses.

More about Phoenix Biotech Acquisition Corp's Market Share

Market Cap. Revenues TTM Net Income TTM
$ 437.355 mill. $ - mill. $ -44.738 mill.


Intellia Therapeutics Inc
Share Performance



+1.35%
Over The Past 5 Days
Intellia Therapeutics Inc
Profile

Intellia Therapeutics Inc is a biotechnology company focused on developing therapies based on CRISPR/Cas9 gene editing technology.

More about Intellia Therapeutics Inc 's Market Share

Market Cap. Revenues TTM Net Income TTM
$ 1,508.378 mill. $ 66.092 mill. $ -394.596 mill.


Metagenomi Therapeutics Inc
Share Performance



-15.71%
This Quarter
Metagenomi Therapeutics Inc
Profile

The company conducts research and development in genome editing technology and clinical trials.

More about Metagenomi Therapeutics Inc 's Market Share

Market Cap. Revenues TTM Net Income TTM
$ 44.437 mill. $ - mill. $ -93.462 mill.


Meiragtx Holdings Plc
Share Performance



-6.88%
Over The Past 5 Days
Meiragtx Holdings Plc
Profile

MeiraGTx Holdings Plc is a biotechnology company focused on developing gene therapies for inherited and acquired diseases. They leverage their proprietary technology to develop and commercialize innovative treatments that address unmet medical needs.

More about Meiragtx Holdings Plc's Market Share

Market Cap. Revenues TTM Net Income TTM
$ 1,122.766 mill. $ 79.758 mill. $ -120.533 mill.

38 more competitors available

Sign in to see all competitors

Sign In Create Free Account

Sources: Caribou Biosciences Inc’s official press releases and regulatory filings; CSIMarket.com’s market research; and the financial filings and press releases of other companies cited in this report.
Updated on:
Focus of this report: publicly traded companies.
For your research, we’ve provided 10 tables on Caribou Biosciences Inc versus competitors, including market share analysis.
You can find them in the navigation menu under Competition.
To download the tables, please subscribe.



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.